Vaccination for hepatitis C - characterising the host immune response and its implications for a successful therapeutic vaccine
<p>This thesis explores the first-ever administration of a prime/boost combination of adenovirus and MVA vector based vaccines that target hepatitis C virus (HCV) infection to humans. Therapeutic application of these vaccines in patients with chronic HCV infection is first detailed, together w...
Auteurs principaux: | Halliday, J, John Halliday |
---|---|
Autres auteurs: | Barnes, E |
Format: | Thèse |
Langue: | English |
Publié: |
2013
|
Sujets: |
Documents similaires
-
Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
par: Antrobus, R
Publié: (2014) -
Characterising novel vaccine adjuvants in eliciting antigen-specific CD8+ T cell immunity
par: He, A
Publié: (2023) -
The development of novel therapeutic vaccines for chronic hepatitis B infection
par: Cargill, TN
Publié: (2021) -
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
par: Hennig, B, et autres
Publié: (2008) -
Predictive signatures of immune response to vaccination and implications of the immune setpoint remodeling
par: Irene Ramos
Publié: (2025-02-01)